Telix Pharmaceuticals | TLX - Current Assets


Telix Pharmaceuticals reported AUD330.28M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Cochlear AUD 1.37B 43.9M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Integral Diagnostics AUD 74.82M 9.15M Jun/2024
Mayne Pharma AUD 460.59M 14.71M Jun/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Mesoblast USD 202.48M 1.87M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Pacific Edge NZD 13.77M 15.81M Jun/2026
Paradigm Biopharmaceuticals AUD 21.67M 2.46M Dec/2025
Polynovo AUD 69.23M 7.87M Dec/2025
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 4.06B 245.26M Mar/2026
Sonic Healthcare AUD 2.3B 52.76M Dec/2024